- Home
- ENGN vs MLAB Comparison
ENGN vs MLAB Comparison
Compare ENGN & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENGN | MLAB |
|---|---|---|
| Founded | 1999 | 1982 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 441.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ENGN | MLAB |
|---|---|---|
| Price | $8.42 | $77.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $22.71 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 528.5K | 177.7K |
| Earning Date | 12-19-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $245,255,000.00 |
| Revenue This Year | N/A | $4.96 |
| Revenue Next Year | N/A | $5.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.39 |
| 52 Week Low | $2.65 | $55.45 |
| 52 Week High | $11.14 | $155.12 |
Technical Indicators
Market Signals| Indicator | ENGN | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 53.95 |
| Support Level | $7.77 | $77.36 |
| Resistance Level | $9.14 | $79.91 |
| Average True Range (ATR) | 0.60 | 3.54 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 58.43 | 49.84 |
Price Performance
Historical ComparisonAbout ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.